Kazia Therapeutics Ltd (KZIA) stock
KZIANasdaqPharmaceutical PreparationsFiscal year ends June 30
$5.49+0.18 (+3.39%)
Close on Nov 18, 2026Market cap $8.89MP/E –Yield –
Kazia Therapeutics profit margin
Profit margin (net margin) is net income as a percentage of revenue.
For fiscal 2025 it was -49290.5%, against -1160.2% the year before. The highest annual figure on record is -55.5% in fiscal 2021.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | -49290.5% | −48130.3 |
| FY2024 | Jun 30, 2024 | -1160.2% | −1104.8 |
| FY2021 | Jun 30, 2021 | -55.5% | +5019.3 |
| FY2018 | Jun 30, 2018 | -5074.8% | −789.6 |
| FY2017 | Jun 30, 2017 | -4285.1% | −1314.0 |
| FY2016 | Jun 30, 2016 | -2971.2% | – |
See a number that looks wrong?